KeyBanc raised the firm’s price target on ResMed (RMD) to $266 from $251 and keeps an Overweight rating on the shares following the Q1 earnings report. KeyBanc was encouraged by the broad ...
Over the last year, Resmed share price has been traded in a range of 80.58, hitting a high of 260.00, and a low of 179.42.
RBC Capital raised the firm’s price target on ResMed (RMD) to $232 from $224 and keeps a Sector Perform rating on the shares. The company reported a strong Q1 result with double digit revenue ...
Although the Resmed share price is not as good value as it was six months ago, the ASX healthcare share seems to have a promising future.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Price elasticity of supply is the responsiveness of a supply of a good or service after a change in its market price. According to basic economic theory, the supply of a good will increase when ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...
Upgrade your Yahoo Finance plan to get complete details for ResMed Inc. Get advanced tools and insights to navigate the markets.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈